200 related articles for article (PubMed ID: 24599971)
1. Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice.
Benesch MG; Tang X; Maeda T; Ohhata A; Zhao YY; Kok BP; Dewald J; Hitt M; Curtis JM; McMullen TP; Brindley DN
FASEB J; 2014 Jun; 28(6):2655-66. PubMed ID: 24599971
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions.
Benesch MG; Ko YM; McMullen TP; Brindley DN
FEBS Lett; 2014 Aug; 588(16):2712-27. PubMed ID: 24560789
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells.
Gaetano CG; Samadi N; Tomsig JL; Macdonald TL; Lynch KR; Brindley DN
Mol Carcinog; 2009 Sep; 48(9):801-9. PubMed ID: 19204929
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer.
Benesch MG; Ko YM; Tang X; Dewald J; Lopez-Campistrous A; Zhao YY; Lai R; Curtis JM; Brindley DN; McMullen TP
Endocr Relat Cancer; 2015 Aug; 22(4):593-607. PubMed ID: 26037280
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
Tang X; Wang X; Zhao YY; Curtis JM; Brindley DN
Mol Cancer; 2017 Feb; 16(1):36. PubMed ID: 28178994
[TBL] [Abstract][Full Text] [Related]
9. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.
Kuonen F; Laurent J; Secondini C; Lorusso G; Stehle JC; Rausch T; Faes-Van't Hull E; Bieler G; Alghisi GC; Schwendener R; Andrejevic-Blant S; Mirimanoff RO; Rüegg C
Clin Cancer Res; 2012 Aug; 18(16):4365-74. PubMed ID: 22711708
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
[TBL] [Abstract][Full Text] [Related]
12. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer.
Quan M; Cui JJ; Feng X; Huang Q
Tumour Biol; 2017 Mar; 39(3):1010428317694544. PubMed ID: 28347252
[TBL] [Abstract][Full Text] [Related]
13. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
[TBL] [Abstract][Full Text] [Related]
14. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
Brindley DN; Tang X; Meng G; Benesch MGK
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest.
Samadi N; Bekele RT; Goping IS; Schang LM; Brindley DN
PLoS One; 2011; 6(5):e20608. PubMed ID: 21647386
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
[TBL] [Abstract][Full Text] [Related]
17. Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs.
Shinde A; Tang X; Singh R; Brindley DN
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201482
[TBL] [Abstract][Full Text] [Related]
18. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.
Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN
FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367
[TBL] [Abstract][Full Text] [Related]
19. A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension.
Saga H; Ohhata A; Hayashi A; Katoh M; Maeda T; Mizuno H; Takada Y; Komichi Y; Ota H; Matsumura N; Shibaya M; Sugiyama T; Nakade S; Kishikawa K
PLoS One; 2014; 9(4):e93230. PubMed ID: 24747415
[TBL] [Abstract][Full Text] [Related]
20. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]